Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1499-1507

  Kelley, Ann E ^a   Bless, Elizabeth P ^b   Swanson, Chad J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NALTREXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SELECTIVITY; FEEDING BEHAVIOR; FOOD DEPRIVATION; INGESTION; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REWARD;

ANIMALS; DRINKING BEHAVIOR; FEEDING BEHAVIOR; MALE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SATIATION; SUCROSE;

EID: 0030425435     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. APFELBAUM, M. AND MANDENOFF, A.: Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol. Biochem. Behav. 15: 89-91, 1981.
2. ARJUNE, D. AND BODNAR, R. J.: Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid agonist nor-binaltorphimine. Brain Res. 534: 313-316, 1990.
3. 6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the κ opioid receptor. Pharmacol. Biochem. Behav. 39: 429-436, 1991.
4. ARJUNE, A., STANDIFER, K. M., PASTERNAK, G. W. AND BODNAR, R. J.: Reduction by central β-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535: 101-109, 1990.
5. BAKSHI, V. P. AND KELLEY, A. E.: Striatal regulation of morphine-induced hyperphagia: An anatomical mapping study. Psychopharmacology 111: 207-214, 1993a.
6. BAKSHI, V. P. AND KELLEY, A. E.: Feeding induced by opioid stimulation of the ventral striatum: Role of opiate receptor subtypes. J. Pharmacol. Exp. Ther. 265: 1253-1260, 1993b.
7. BAKSHI, V. P. AND KELLEY, A. E.: Sensitization and conditioning of feeding following multiple morphine microinjections into the nucleus accumbens. Brain Res. 648: 342-346, 1994.
8. 5]enkephalin binding to mouse brain membranes. Life Sci. 33: 2439-2448, 1983.
9. BECZKOWSKA, I. W., BOWEN, W. D. AND BODNAR, R. J.: Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589: 291-301, 1992a.
10. BECZKOWSKA, I. W., KOCH, J. E. AND BODNAR, R. J.: Naltrexone, serotonin receptor subtype agonists and glucoprivic intake: I. 2-Deoxy-d-glucose. Pharmacol. Biochem. Behav. 42: 661-669, 1992b.
11. BECZKOWSKA, I. W., KOCH, J. E., BOSTOCK, M. E., LEIBOWITZ, S. F. AND BODNAR, R. J.: Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 618: 261-270, 1993.
12. BODNAR, R. J. AND GEARY, N.: Roles of opioid receptor subtypes in rats' feeding behavior. Appetite 17: 239, 1991.
13. BODNAR, R. J., GLASS, M. J., RAGNAUTH, A. AND COOPER, M. L.: General, μ and κ opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700: 205-212, 1995.
14. BROWN, D. R. AND HOLTZMAN, S. G.: Suppression of drinking by naloxone in the rat: A further characterization. Eur. J. Pharmacol. 69: 331-340, 1981.
15. CALCAGNETTI, D. J., CALCAGNETTI, R. L. AND FANSELOW, M. S.: Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution. Pharmacol. Biochem. Behav. 35: 69-73, 1990.
16. CALCAGNETTI, D. J. AND REID, L. D.: Morphine and acceptability of putative reinforcers. Pharmacol. Biochem. Behav. 18: 567-569, 1983.
17. CARR, K. D. AND SIMON, E. J.: Effects of naloxone and its quaternary analogue on stimulation-induced feeding. Neuropharmacology 22: 127-130, 1983.
18. COLE, J. L., LEVENTHAL, L., PASTERNAK, G. W., BOWEN, W. D. AND BODNAR, R. J.: Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678: 168-176, 1995.
19. COOPER, S. J.: Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology 22: 323-328, 1983.
20. COOPER, S. J., JACKSON, A. AND KIRKHAM, T. C.: Endorphins and food intake: Kappa opioid receptor agonists and hyperphagia. Pharmacol. Biochem. Behav. 23: 889-901, 1985.
21. COOPER, S. J. AND KIRKHAM, T. C.: Opioid mechanisms in the control of food consumption and taste preferences. In Handbook of Experimental Pharmacology, vol. 104/II, Opioids II, ed. by A. Herz, pp. 239-262, Springer-Verlag, Berlin, 1993.
22. COOPER, S. J. AND TURKISH, S.: Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol. Biochem. Behav. 33: 17-20, 1989.
23. CUNNINGHAM, S. T. AND KELLEY, A. E.: Opiate infusion into nucleus accumbens: Contrasting effects on motor activity and responding for conditioned reward. Brain Res. 588: 104-114, 1992.
24. CZIRR, S. A. AND REID, L. D.: Demonstrating morphine's potentiating effects on sucrose-intake. Brain Res. Bull. 17: 639-642, 1986.
25. D'AMATO, R. J. AND HOLADAY, J. W.: Multiple opioid receptors in endotoxic shock: Evidence for delta involvement and mu-delta interactions in vivo. Proc. Natl. Acad. Sci. U.S.A. 81: 2892-2901, 1984.
26. DEMOLIOU-MASON, C. D. AND BARNARD, E. A.: Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes. J. Neurochem. 46: 1118-1128, 1986.
27. DREWNOWSKI, A., KRAHN, D. D., DEMITRACK, M. A., NAIRN, K. AND GOSNELL, B. A.: Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol. Behav. 51: 371-379, 1992.
28. EVANS, K. R. AND VACCARINO, F. J.: Intra-nucleus accumbens amphetamine: Dose-dependent effects on food intake. Pharmacol. Biochem. Behav. 25: 1149-1151, 1986.
29. EVANS, K. R. AND VACCARINO, F. J.: Amphetamine- and morphine-induced feeding: Evidence for involvement of reward mechanisms. Neurosci. Biobehav. Rev. 14: 9-22, 1990.
30. FANTINO, M., HOSOTTE, J. AND APFELBAUM, M.: An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am. J. Physiol. 251: R91-R96, 1986.
31. GOEDERS, N. E., LANE, J. D. AND SMITH, J. E.: Intracranial self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20: 451-455, 1984.
32. GOLDSTEIN, A. AND NAIDU, A.: Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36: 265-272, 1989.
33. GOSNELL, B. A.: Central structures involved in opioid-induced feeding. Fed. Proc. 46: 163-167, 1987.
34. GOSNELL, B. A., KRAHN, D. D. AND MAJCHRZAK, M. J.: The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol. Biochem. Behav. 37: 207-212, 1990.
35. GOSNELL, B. A. AND MAJCHRZAK, M. J.: Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats. Pharmacol. Biochem. Behav. 33: 805-810, 1989.
36. GOSNELL, B. A., MORLEY, J. E. AND LEVINE, A. S.: Opioid-induced feeding: Localization of sensitive brain sites. Brain Res. 369: 177-184, 1986.
37. GRANDISON, L. AND GUIDOTTI, A.: Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16: 533-536, 1977.
38. HERNANDEZ, L. AND HOEBEL, B. G.: Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42: 1705-1712, 1988.
39. HEYMAN, J. S., JIANG, Q., ROTHMAN, R. B., MOSBERG, H. I. AND PORRECA, F.: Modulation of μ-mediated antinociception by delta agonists: Characterization with antagonists. Eur. J. Pharmacol. 169: 43-52, 1989.
40. HOLTZMAN, S. G.: Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharmacol. Exp. Ther. 189: 51-60, 1974.
41. HOLTZMAN, S. G.: Effects of narcotic antagonists on fluid intake in the rat. Life Sci. 16: 1465-1470, 1975.
42. ISLAM, A. K. AND BODNAR, R. J.: Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res. 508: 293-296, 1990.
43. JONAS, J. M. AND GOLD, M. S.: Treatment of antidepressant resistant bulimia with naltrexone. Int. J. Psychiatry Med. 16: 305-309, 1987.
44. KIRKHAM, T. C. AND BLUNDELL, J. E.: Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol. Biochem. Behav. 26: 515-520, 1987.
45. KIRKHAM, T. C. AND COOPER, S. J.: Attenuation of sham feeding by naloxone is stereospecific: Evidence for opioid mediation of orosensory reward. Physiol. Behav. 43: 845-847, 1988a.
46. KIRKHAM, T. C. AND COOPER, S. J.: Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44: 491-494, 1988b.
47. KOCH, J. E. AND BODNAR, R. J.: Involvement of mu-1 and mu-2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 53: 603-605, 1993.
48. KOCH, J. E. AND BODNAR, R. J.: Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res. 657: 191-201, 1994.
49. KOCH, J. E., GLASS, M. J., COOPER, M. L. AND BODNAR, R. J.: Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 66: 951-957, 1995.
50. KOOB, G. F. AND BLOOM, F. E.: Cellular and molecular mechanisms of drug dependence. Science (Wash. DC) 242: 715-723, 1988.
51. KOTZ, C. M., GRACE, M. K., BILLINGTON, C. J. AND LEVINE, A. S.: The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 631: 325-328, 1993.
52. KRISHNAN-SARIN, S., JING, S.-L., KURTZ, D. L., ZWEIFEL, M., PORTOGHESE, P. S., LI, T.-K. AND FROELICH, J. C.: The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology 120: 177-185, 1995.
53. LE MAGNEN, J., MARFAING-JALLAT, P., MICELI, D. AND DEVOS, M.: Pain modulating and reward systems: A single brain mechanism? Pharmacol. Biochem. Behav. 12: 729-733, 1980.
54. LEIBOWITZ, S. F.: Brain neurotransmitters and appetite regulation. Psychopharmacol. Bull. 21: 412-417, 1985.
55. LEVINE, A. S., GRACE, M. AND BILLINGTON, C. J.: β-Funaltrexamine (β-FNA) decreases deprivation and opioid-induced feeding. Brain Res. 562: 281-284, 1991.
56. LEVINE, A. S., GRACE, M., BILLINGTON, C. J. AND PORTOGHESE, P. S.: Norbinaltorphimine decreases deprivation and opioid-induced feeding. Brain Res. 534: 60-64, 1990.
57. LEVINE, A. S., MORLEY, J. E., GOSNELL, B. A., BILLINGTON, C. J. AND BARTNESS, T. J.: Opioids and consummatory behavior. Brain Res. Bull. 14: 663-672, 1985.
58. MAJEED, N. H., PRZEWLOCKA, B., WEDZONY, K. AND PRZEWLOCKI, R.: Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats. Peptides 7: 711-716, 1986.
59. MALDONADO-IRIZARRY, C. S., SWANSON, C. J. AND KELLEY, A. E.: Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci. 15: 6779-6788, 1995.
60. MANSOUR, A., KACHATURIAN, H., LEWIS, M. E., AKIL, H. AND WATSON, S. J.: Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7: 2445-2464, 1987.
61. MARTIN, W. R., WIKLER, A., EADES, C. G. AND PESCOR, F. T.: Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4: 247-260, 1963.
62. MCLEAN, S. AND HOEBEL, B. G.: Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides 4: 287-292, 1983.
63. MORLEY, J. E.: Neuropeptide regulation of appetite and weight. Endocr. Rev. 8: 256-287, 1987.
64. MORLEY, J. E. AND LEVINE, A. S.: Stress-induced eating is mediated through endogenous opiates. Science (Wash. DC) 209: 1259-1261, 1980.
65. MORLEY, J. E. AND LEVINE, A. S.: Dynorphin-(1-13) induces spontaneous feeding in rats. Life Sci. 29: 1901-1903, 1981.
66. MORLEY, J. E., LEVINE, A. S., GRACE, M. AND KNEIP, J.: An investigation of the role of kappa opiate receptors in the initiation of feeding. Life Sci. 31: 2617-2626, 1982.
67. MUCHA, R. F. AND IVERSEN, S. D.: Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 397: 214-224, 1986.
68. 1 sites. Mol. Pharmacol. 25: 20-37, 1984.
69. PAPADOUKA, V. AND CARR, K. D.: The role of multiple opioid receptors in the maintenance of stimulation-induced feeding. Brain Res. 639: 42-48, 1994.
70. PORRECA, F., TAKEMORI, A. E., SULTANA, M., PORTOGHESE, P. S., BOWDEN, W. D. AND MOSBERG, H. I.: Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 263: 147-152, 1992.
71. PORTOGHESE, P. S., LARSON, D. L., SAYRE, L. M., FREIS, D. S. AND TAKEMORI, A. E.: A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23: 233-234, 1980.
72. PORTOGHESE, P. S., LIPOWSKI, A. W. AND TAKEMORI, A. E.: Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40: 1287-1292, 1987.
73. PORTOGHESE, P. S., SULTANA, M. AND TAKEMORI, A. E.: Naltrindole 5′-isothiocyanate: A nonequilibrium, highly selective delta opioid receptor antagonist. J. Med. Chem. 33: 1547-1548, 1990.
74. REID, L. D., ED.: Opioids, Bulimia and Alcohol Abuse and Alcoholism, pp. 1-393, Springer-Verlag, New York, 1990.
75. ROCKWOOD, G. A. AND REID, L. D.: Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29: 1175-1178, 1982.
76. ROSENTHAL, R. AND ROSNOW, R. L.: Essentials of Behavioral Research: Methods and Data Analysis, McGraw-Hill, New York, 1991.
77. SANGER, D. J.: Endorphinergic mechanisms in the control of food and water intake. Appetite 2: 193-208, 1981.
78. 125I]β-endorphin to opioid receptors in rat striatal membranes: Biochemical evidence for the existence of a mu/delta opioid receptor complex. J. Pharmacol. Exp. Ther. 253: 419-426, 1990.
79. SCHOFFELMEER, A. N. M., DEVRIES, T. J., HOGENBOOM, F., HRUBY, V. J., PORTOGHESE, P. S. AND MULDER, A. H.: Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain. J. Pharmacol. Exp. Ther. 263: 20-24, 1992.
80. SIVIY, S. M. AND REID, L. D.: Endorphinergic modulation of acceptability of putative reinforcers. Appetite 4: 249-257, 1983.
81. SMITH, G. P. AND GIBBS, J.: Postprandial satiety. Prog. Psychobiol. Physiol. Psychol. 8: 179-242, 1979.
82. STANLEY, B. G., LANTHIER, D. AND LEIBOWITZ, S. F.: Multiple brain sites sensitive to feeding stimulation by opioid agonists: A cannula mapping study. Pharmacol. Biochem. Behav. 31: 825-832, 1989.
83. STAPELFELD, A., HAMMOND, D. L. AND RAFFERTY, M. F.: Antinociception after intracerebroventricular administration of naltrindole in the mouse. Eur. J. Pharmacol. 214: 273-276, 1992.
84. TAKEMORI, A. E., SULTANA, M., NAGASE, H. AND PORTOGHESE, P. S.: Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone. Life Sci. 50: 1491-1495, 1992.
85. TEMPEL, A. AND ZUKIN, R. S.: Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. U.S.A. 84: 4308-4312, 1987.
86. 5]enkephalin on feeding and temperature in the rat. Eur. J. Pharmacol. 96: 243-249, 1983.
87. UKAI, M. AND HOLTZMAN, S. G.: Suppression of deprivation-induced water intake in the rat by opioid antagonists: Central sites of action. Psychopharmacology 91: 279-284, 1987.
88. UKAI, M. AND HOLTZMAN, S. G.: Effects of β-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153: 161-165, 1988.
89. VAN DER KOOY, D., MUCHA, R. F., O'SHAUGHNESSEY, M. AND BUCENIEKS, P.: Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res. 243: 107-117, 1982.
90. VOLPICELLI, J. R., O'BRIEN, C. P., ALTERMAN, A. I. AND HAYASHIDA, M.: Naltrexone and the treatment of alcohol-dependence: Initial observations. In Opioids, Bulimia, and Alcohol Abuse and Alcoholism, ed. by L. D. Reid, pp. 195-214, Springer-Verlag, New York, 1990.
91. WARD, S. J., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J. Pharmacol. Exp. Ther. 220: 494-498, 1982.
92. WISE, R. A. AND BOZARTH, M. A.: A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492, 1987.
93. WOODS, J. S. AND LEIBOWITZ, S. F.: Hypothalamic sites sensitive to morphine and naloxone: Effects on feeding behavior. Pharmacol. Biochem. Behav. 23: 431-438, 1985.
94. ZAHM, D. S. AND BROG, J. S.: On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50: 751-767, 1992.